A COMPARISON OF THE EFFICACY OF CETIRIZINE AND TERFENADINE - A DOUBLE-BLIND, CONTROLLED-STUDY OF CHRONIC IDIOPATHIC URTICARIA

被引:21
|
作者
ANDRI, L [1 ]
SENNA, GE [1 ]
BETTELI, C [1 ]
GIVANNI, S [1 ]
ANDRI, G [1 ]
LOMBARDI, C [1 ]
MEZZELANI, P [1 ]
机构
[1] UNIV VERONA, IST CLIN MED, I-37100 VERONA, ITALY
关键词
ANTIHISTAMINES; CETIRIZINE; TERFENADINE; URTICARIA;
D O I
10.1111/j.1398-9995.1993.tb02406.x
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
In a 20-d, double-blind, randomized, parallel study, the efficacy of cetirizine and terfenadine was compared in 30 patients with chronic idiopathic urticaria. Subjects were randomly divided into two 15-patient groups. The first group was given cetirizine (10 mg once daily); the second terfenadine (60 mg twice daily). Cetirizine proved to be more effective than terfenadine in controlling urticaria symptoms. In fact, the score of the investigators' overall assessment was significantly lower in the cetirizine-treated group than in the terfenadine-treated group. Moreover, patient evaluation by a visual analog scale and symptoms assessed on a 4-point scale showed a better improvement in the cetirizine group. The number and severity of side-effects were similar in both treatment groups.
引用
收藏
页码:358 / 365
页数:8
相关论文
共 50 条
  • [1] Safety and efficacy of cetirizine versus cetirizine plus ranitidine in chronic urticaria: Double-blind randomized placebo-controlled study
    Guevara-Gutierrez, Elizabeth
    Bonilla-Lopez, Sonia
    Hernandez-Arana, Socorro
    Tlacuilo-Parra, Alberto
    JOURNAL OF DERMATOLOGICAL TREATMENT, 2015, 26 (06) : 548 - 550
  • [2] Theophylline as 'add-on' therapy to cetirizine in patients with chronic idiopathic urticaria - A randomized, double-blind, placebo-controlled pilot study
    Kalogeromitros, D
    Kempuraj, D
    Katsarou-Katsari, A
    Makris, M
    Gregoriou, S
    Papaliodis, D
    Theoharides, TC
    INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, 2006, 139 (03) : 258 - 264
  • [3] Double-blind placebo-controlled study of the efficacy of oral terfenadine in the treatment of chronic fatigue syndrome
    Steinberg, P
    McNutt, BE
    Marshall, P
    Schenck, C
    Lurie, N
    Pheley, A
    Peterson, PK
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1996, 97 (01) : 119 - 126
  • [4] MULTICENTER DOUBLE-BLIND COMPARATIVE-STUDY OF TERFENADINE AND CETIRIZINE IN HAY-FEVER
    CAIAFFA, MF
    IUDICE, A
    MACCHIA, L
    TURSI, A
    VERGALLO, G
    SACERDOTI, G
    VENUTI, A
    DELLATORRE, F
    MUSARRA, A
    JOURNAL OF INVESTIGATIONAL ALLERGOLOGY & CLINICAL IMMUNOLOGY, 1992, 2 (03) : 162 - 166
  • [5] Comparative efficacy and safety of loratadine and cetirizine in patients with chronic idiopathic urticaria
    Patel, P
    Danzig, M
    ADVANCES IN THERAPY, 1997, 14 (06) : 318 - 322
  • [6] Comparative efficacy of cetirizine and levocetirizine in chronic idiopathic urticaria
    Garg, Geeta
    Thami, Gurvinder P.
    JOURNAL OF DERMATOLOGICAL TREATMENT, 2007, 18 (01) : 23 - 24
  • [7] Double-blind crossover study of high-dose cetirizine in cholinergic urticaria
    Zuberbier, T
    Munzberger, C
    Haustein, U
    Trippas, E
    Burtin, B
    Mariz, SD
    Henz, BM
    DERMATOLOGY, 1996, 193 (04) : 324 - 327
  • [8] Double-Blind Placebo-Controlled Trial of Dapsone in Antihistamine Refractory Chronic Idiopathic Urticaria
    Morgan, Matt
    Cooke, Andrew
    Rogers, Laura
    Adams-Huet, Beverley
    Khan, David A.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2014, 2 (05) : 601 - 606
  • [9] Comparison of the efficacy and safety of bilastine 20 mg vs levocetirizine 5 mg for the treatment of chronic idiopathic urticaria: a multi-centre, double-blind, randomized, placebo-controlled study
    Zuberbier, T.
    Oanta, A.
    Bogacka, E.
    Medina, I.
    Wesel, F.
    Uhl, P.
    Antepara, I.
    Jauregui, I.
    Valiente, R.
    ALLERGY, 2010, 65 (04) : 516 - 528
  • [10] Comparison of the Efficacy of Olopatadine and Fexofenadine in Chronic Idiopathic Urticaria Patients: A Crossover Study
    Tanizaki, Hideaki
    Yamamoto, Yosuke
    Nakamizo, Satoshi
    Otsuka, Atsushi
    Miyachi, Yoshiki
    Kabashima, Kenji
    PHARMACOLOGY, 2015, 95 (1-2) : 32 - 35